Filing Flows › Novanta (NOVT) › R&D spending
Novanta (NOVT) R&D spending by quarter
Novanta's R&D spending was $24.0M in Q2 2026 (second quarter 2026), +3% from Q1 2026. Over the last 7 quarters it ranged from $22.9M (Q4 2025) to $25.3M (Q2 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $24.0M | +3% | -5% |
| Q1 2026 | $23.3M | +2% | +0.1% |
| Q4 2025 | $22.9M | -5% | -10% |
| Q3 2025 | $24.1M | -5% | — |
| Q2 2025 | $25.3M | +9% | — |
| Q1 2025 | $23.2M | -8% | — |
| Q4 2024 | $25.3M | — | — |
Q2 2026 at a glance
Novanta, Q2 2026: revenue $266M (+10% year over year), operating margin 6.8%, net earnings $12.5M, operating cash flow $64.9M. The chart follows the revenue to costs, profit and cash.
Questions
What is Novanta's R&D spending?
Novanta's R&D spending was $24.0M in Q2 2026 (second quarter 2026), +3% from Q1 2026.
How has Novanta's R&D spending changed?
Over the last 7 quarters it ranged from $22.9M (Q4 2025) to $25.3M (Q2 2025).